Annual Financial Report

AI SummaryClose X

BSF Enterprise PLC has published its Annual Report and Consolidated Financial Statements for the year ended 30 September 2025, detailing significant commercial and technical progress across its subsidiaries. The company reported a reduced net loss of £1,013,527, down from £1,672,291 in the prior year, attributed to cost control and increased grant income. Key developments include the launch of CytoBoost™ and expansion of City-Mix™, a major breakthrough with 2mm-thick scaffold-free leather, and a licensing agreement for liquid cornea technology. Strategic fundraising initiatives, including shareholder approval for up to £15 million via warrants, are in place to support commercialisation, expansion, and potential acquisitions.

Disclaimer*

UK 100

Latest directors dealings